Engineered nanomaterial captures off-target cancer drug to prevent tissue damage: Super-capacity, cellulose-based material may enable high-dose targeted treatments

Standard chemotherapies may efficiently kill cancer cells, but they also pose significant risks to healthy cells, resulting in secondary illness and a diminished quality of life for patients. To prevent the previously unavoidable damage, researchers have developed a new class of nanomaterials engineered to capture chemotherapy drugs before they interact with healthy tissue.